Sign In
Buy ENLV
$0.611
-0.0122 (-1.96%)
At Close: Jun 23, 2026
Israel Patent Office Grants New Patent Covering Enlivex’s Allocetra Immunotherapy Treatment
12:13pm, Monday, 09'th Mar 2020
Nes-Ziona, March 09, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the Israel Patent Office granted a new patent (#239236) coverin
US Stock Market Weekly Update March 2- March 6, 2020
01:48am, Monday, 09'th Mar 2020
Another week with increased levels of volatility for the US stock market, bond yields declining to record low levels and an unexpected Fed rate cut of 50 basis points, depreciating the US dollar. But
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu
Enlivex Therapeutics Closes $16.75 Million Registered Direct Offering
01:15pm, Thursday, 05'th Mar 2020
Nes-Ziona, Israel, March 05, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced the closing of its previously announced registered di
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
01:05pm, Thursday, 05'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In
Enlivex Therapeutics Confirms Public Statements Made by the Head of Israel Economic and Commercial Mission to South Korea
01:53pm, Tuesday, 03'rd Mar 2020
Nes-Ziona, Israel, March 03, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today confirmed the public statements made by the Head of Israel E
Enlivex Therapeutics Announces $16.75 Million Registered Direct Offering
01:00pm, Monday, 02'nd Mar 2020
Nes-Ziona, Israel, March 02, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced that it has entered into definitive agreements with c
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
06:46pm, Wednesday, 26'th Feb 2020
Nes-Ziona, Israel, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced the closing of its previously announced registered dir
18 Medical Stocks To Watch Amid The Coronavirus Outbreak
08:25pm, Tuesday, 25'th Feb 2020
Airlines, hotels, casinos and other stocks continue to fall as fear of the coronavirus grows worldwide and all but halts activity in the virus epicenter of Wuhan, China. Alpha Pro Tech, Ltd. (NYSE: A
Enlivex Therapeutics Announces $8.0 Million Registered Direct Offering
06:54pm, Monday, 24'th Feb 2020
Nes-Ziona, Israel, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced that it has entered into definitive agreements with ce
Mid-Morning Market Update: Markets Open Lower; Coronavirus Spreads Outside China
03:17pm, Monday, 24'th Feb 2020
Following the market opening Monday, the Dow traded down 2.47% to 28276.64 while the NASDAQ fell 2.69% to 9,318.61. The S&P also fell, dropping 2.37% to 3,258.77.
Leading and...
GILD, GOLD among premarket gainers
02:17pm, Monday, 24'th Feb 2020
NGM Biopharmaceuticals (NASDAQ:NGM) +67% after aldafermin phase 2 results.NanoViricides (NYSEMKT:NNVC) +39% on drugmakers working on coronavirus.Enlivex Therapeutics (NASDAQ:ENLV) +37% after disclo
Nes-Ziona, Israel, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced that it is initiating a plan to increase its manufactu
Nes-Ziona, Israel, Feb. 20, 2020 -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the company was selected, for a.
UBS upgrades Madrigal Pharma in premarket analyst action
01:10pm, Thursday, 09'th Jan 2020
Aptose Biosciences (APS CN) initiated with Overweight rating at Piper Sandler. Shares up 2% premarket in U.S. (NASDAQ:APTO).BioDelivery Sciences (NASDAQ:BDSI) initiated with Overweight rating and $9
